Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Work
Year: 2023
Type: article
Abstract: BackgroundAbiraterone acetate plus prednisolone (herein referred to as abiraterone) or enzalutamide added at the start of androgen deprivation therapy improves outcomes for patients with metastatic pr... more
Source: The Lancet Oncology
Institutions University College London, Royal London Hospital, Medical Research Council, Salford Royal NHS Foundation Trust, St James's University Hospital +26 more
Cites: 31
Cited by: 49
Related to: 10
FWCI: 20.93
Citation percentile (by year/subfield): 100
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $6,300